Circulating Markers of Endothelial Dysfunction Interact With Proteinuria in Predicting Mortality in Renal Transplant Recipients

Background. Proteinuria is associated with endothelial dysfunction (ED) and increased mortality. We investigated whether urinary protein excretion (UPE) is correlated with markers of ED and whether these markers affect the association of proteinuria with mortality in renal transplant recipients (RTR). Methods. Six hundred four RTR with a functioning graft for more than 1 year were included. RTR were divided according to UPE: less than 0.3, 0.3 to 1.0, and more than 1.0 g/24 hr. Soluble intercellular adhesion molecule type 1 (sICAM-1) and soluble vascular cellular adhesion molecule type 1 (sVCAM-1) were measured using ELISA. Results. UPE (0.2 [0.0–0.5] g/24 hr), sICAM-1 (603 (514–721) ng/mL), and sVCAM-1 (952 [769–1196] ng/mL) were measured at 6.0 (2.6–11.4) years posttransplant. During follow-up for 5.3 (4.7–5.7) years, 94 (16%) RTR died. UPE was correlated with sVCAM-1 (standardized &bgr;=0.13, P=0.001) but not with sICAM-1 (standardized &bgr;=0.04, P=0.3). RTR with UPE more than 1.0 g/24 hr and high sICAM-1 (hazard ratio=4.7, 95% confidence interval 2.3–9.7, P<0.0001) or sVCAM-1 (hazard ratio=4.2, 95% confidence interval 2.0–8.6, P=0.0001) concentrations were at increased risk for death, whereas RTR with UPE more than 1.0 g/24 hr and low concentrations of sICAM-1 and sVCAM-1 were not. Conclusions. In RTR, UPE is correlated with sVCAM-1 but not with sICAM-1. Furthermore, RTR with proteinuria and high concentrations of sICAM-1 or sVCAM-1 have an increased risk for death, compared with RTR without proteinuria, whereas this is not the case in RTR with proteinuria but low concentrations of sICAM-1 and sVCAM-1. These results suggest that ED plays a role in the association of proteinuria with mortality after renal transplantation.

[1]  H. Parving,et al.  Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years , 2008, Diabetes Care.

[2]  T. Larson,et al.  Proteinuria After Kidney Transplantation, Relationship to Allograft Histology and Survival , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  H. Vargas-Robles,et al.  Correlation between circulating adhesion molecule levels and albuminuria in type 2 diabetic normotensive patients. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[4]  P. Stenvinkel,et al.  Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  P. Adams.  Long-term patient survival: strategies to improve overall health. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  F. Irie,et al.  The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. , 2006, Kidney international.

[7]  R. Gans,et al.  Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  J. Norrie,et al.  The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis. , 2005, Clinical Nephrology.

[9]  M. Arias,et al.  Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  S. Blankenberg,et al.  Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.

[11]  R. Zietse,et al.  PROTEINURIA AFTER RENAL TRANSPLANTATION AFFECTS NOT ONLY GRAFT SURVIVAL BUT ALSO PATIENT SURVIVAL , 2001, Transplantation.

[12]  K. Rossing,et al.  Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[13]  P. Ridker,et al.  Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men , 1998, The Lancet.

[14]  B. Kasiske,et al.  Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. , 1997, Kidney international. Supplement.

[15]  K. Budde,et al.  Interleukin-6 expression after renal transplantation. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  T. Cavallo,et al.  Proteinuria following renal transplantation: correlation with histopathology and outcome. , 1997, Transplantation proceedings.

[17]  K Borch-Johnsen,et al.  Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study , 1996, BMJ.

[18]  T. Rabelink,et al.  Impaired endothelial function in patients with nephrotic range proteinuria. , 1995, Kidney international.

[19]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[20]  S. Kreiner,et al.  Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. , 1987, British medical journal.

[21]  K. Pennert,et al.  Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden. , 1985, Journal of hypertension.

[22]  J. Alexander,et al.  PROTEINURIA FOLLOWING TRANSPLANTATION: Correlation With Histopathology And Outcome , 1984, Transplantation.

[23]  W. Kannel,et al.  The prognostic significance of proteinuria: the Framingham study. , 1984, American heart journal.

[24]  D. Brennan.  Long-term trends in allograft survival. , 2006, Advances in chronic kidney disease.

[25]  Gian Paolo Rossi,et al.  Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. , 2005, Journal of hypertension.

[26]  P. Merville.  Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens. , 2005, Drugs.

[27]  A. Papagianni,et al.  Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  D. Leehey,et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.

[29]  C. V. van Buren,et al.  Proteinuria in cyclosporine-treated renal transplant recipients. , 1990, Transplantation.